Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Feasibility Study of E7 TCR-T Cell Induction Therapy for Locoregionally Advanced HPV-Associated Cancers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05639972
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:19.928706+00:00
Published At
2026-02-27T00:00:00+00:00
Record Updated At
2026-02-27
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["HPV-Associated Cervical Carcinoma", "HPV-Related Carcinoma", "HPV-Related Malignancy", "HPV Positive Oropharyngeal Squamous Cell Carcinoma", "HPV-Related Adenocarcinoma", "HPV-Related Adenosquamous Carcinoma", "HPV-Related Squamous Cell Carcinoma", "HPV-Related Anal Squamous Cell Carcinoma", "HPV-Related Penile Squamous Cell Carcinoma", "HPV-Related Vulvar Squamous Cell Carcinoma", "HPV-Related Endocervical Adenocarcinoma", "Cervical Cancer", "Oropharynx Cancer", "Anal Cancer", "Vulvar Cancer", "Penile Cancer", "Vaginal Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-27"
protocolSection.identificationModule.nctId
"NCT05639972"
protocolSection.identificationModule.officialTitle
"A Feasibility Study of E7 TCR-T Cell Induction Therapy for Locoregionally Advanced HPV-Associated Cancers"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • HPV-Associated Cervical Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Malignancy (protocolSection.conditionsModule.conditions)
  • HPV Positive Oropharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Adenosquamous Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Anal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Penile Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Vulvar Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Endocervical Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Oropharynx Cancer (protocolSection.conditionsModule.conditions)
  • Anal Cancer (protocolSection.conditionsModule.conditions)
  • Vulvar Cancer (protocolSection.conditionsModule.conditions)
  • Penile Cancer (protocolSection.conditionsModule.conditions)
  • Vaginal Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.